A preview of this full-text is provided by American Society for Microbiology.
Content available from Journal of Virology
This content is subject to copyright. Terms and conditions apply.
Lyssavirus P Protein Isoforms Diverge Significantly in
Subcellular Interactions Underlying Mechanisms of Interferon
Antagonism
Aaron M. Brice,a,b Ashley M. Rozario,cStephen M. Rawlinson,a,b Cassandra T. David,a,b Linda Wiltzer-Bach,bDavid A. Jans,dNaoto Ito,e,f
Toby D. M. Bell,cGregory W. Moseleya,b
a
Viral Pathogenesis Laboratory, Department of Biochemistry and Molecular Biology, Bio21 Institute, The University of Melbourne, Melbourne, Victoria, Australia
b
Viral Pathogenesis Laboratory, Department of Microbiology, Monash University, Clayton, Victoria, Australia
c
School of Chemistry, Monash University, Clayton, Victoria, Australia
d
Nuclear Signaling Laboratory, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia
e
Laboratory of Zoonotic Diseases, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan
f
United Graduate School of Veterinary Sciences, Gifu University, Gifu, Japan
ABSTRACT Viral hijacking of microtubule (MT)-dependent transport is well understood,
but several viruses also express discrete MT-associated proteins (vMAPs), potentially to
modulate MT-dependent processes in the host cell. Specific roles for vMAP-MT interac-
tions include subversion of antiviral responses by P3, an isoform of the P protein of rabies
virus (RABV; genus Lyssavirus), which mediates MT-dependent antagonism of interferon
(IFN)-dependent signal transducers and activators of transcription 1 (STAT1) signaling. P3
also undergoes nucleocytoplasmic trafficking and inhibits STAT1-DNA binding, indicative
of intranuclear roles in a multipronged antagonistic strategy. MT association/STAT1 antag-
onist functions of P3 correlate with pathogenesis, indicating potential as therapeutic tar-
gets. However, key questions remain, including whether other P protein isoforms interact
with MTs, the relationship of these interactions with pathogenesis, and the extent of con-
servation of P3-MT interactions between diverse pathogenic lyssaviruses. Using super-reso-
lution microscopy, live-cell imaging, and immune signaling analyses, we find that multiple
P protein isoforms associate with MTs and that association correlates with pathogenesis.
Furthermore, P3 proteins from different lyssaviruses exhibit variation in intracellular local-
ization phenotypes that are associated with STAT1 antagonist function, whereby P3-MT
association is conserved among lyssaviruses of phylogroup I but not phylogroup II, while
nucleocytoplasmic localization varies between P3 proteins of the same phylogroup within
both phylogroup I and II. Nevertheless, the divergent P3 proteins retain significant IFN an-
tagonist function, indicative of adaptation to favor different inhibitory mechanisms, with
MT interaction important to phylogroup I viruses.
IMPORTANCE Lyssaviruses, including rabies virus, cause rabies, a progressive encephalomy-
elitis that is almost invariably fatal. There are no effective antivirals for symptomatic infec-
tion, and effective application of current vaccines is limited in areas of endemicity, such that
rabies causes ;59,000 deaths per year. Viral subversion of host cell functions, including anti-
viral immunity, is critical to disease, and isoforms of the lyssavirus P protein are central to
the virus-host interface underpinning immune evasion. Here, we show that specific cellular
interactions of P protein isoforms involved in immune evasion vary significantly between
different lyssaviruses, indicative of distinct strategies to evade immune responses. These
findings highlight the diversity of the virus-host interface, an important consideration in the
development of pan-lyssavirus therapeutic approaches.
KEYWORDS immune evasion, lyssavirus, microtubules, nuclear localisation, rabies
virus, super-resolution microscopy
Editor Susana López, Instituto de
Biotecnologia/UNAM
Copyright © 2022 American Society for
Microbiology. All Rights Reserved.
Address correspondence to Gregory W.
Moseley, greg.moseley@monash.edu.
The authors declare no conflict of interest.
Received 9 September 2022
Accepted 9 September 2022
Published 12 October 2022
October 2022 Volume 96 Issue 20 10.1128/jvi.01396-22 1
VIRUS-CELL INTERACTIONS